These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7176752)

  • 1. [Increase in the hematocrit during episodes of hepatic cytolysis in patients with chronic renal insufficiency treated by hemodialysis].
    Lanuza M; Montolíu J; Andreu L; López-Pedret J; Revert L
    Med Clin (Barc); 1982 Nov 1-15; 79(8):384. PubMed ID: 7176752
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of erythropoietin in patients with chronic renal insufficiency and in hemodialysis].
    Cuero CJ; Pérez Guardia E; de Rivera C
    Rev Med Panama; 1996; 21(1-2):55-9. PubMed ID: 8966240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of renal function in renal insufficiency. I. Renal function of the patients under chronic hemodialysis].
    Kawamura J; Okabe T; Yamashita A; Sawanishi K; Katõ T
    Hinyokika Kiyo; 1971 Mar; 17(3):157-86. PubMed ID: 5103947
    [No Abstract]   [Full Text] [Related]  

  • 4. Normalization of hematocrit in regular hemodialysis patients: the role of renal cyst formation.
    Ono K; Kikawa K; Okamoto T; Matsuo H
    Trans Am Soc Artif Intern Organs; 1985; 31():639-43. PubMed ID: 3837523
    [No Abstract]   [Full Text] [Related]  

  • 5. Red cells life span, splenic sequestration and transfusion requirements in chronic renal failure treated by hemodialysis. Effects of bilateral nephrectomy.
    Laurent C; Wittek M; Vereerstraeten P; Toussaint C; Naets JP
    Clin Nephrol; 1974; 2(1):35-40. PubMed ID: 4823492
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemodialysis clearance of ethosuximide in patients with chronic renal disease.
    Marbury TC; Lee CS; Perchalski RJ; Wilder BJ
    Am J Hosp Pharm; 1981 Nov; 38(11):1757-60. PubMed ID: 7304633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Products of lipid peroxidation in the blood plasma of patients with chronic renal insufficiency treated with hemodialysis].
    Nikiforova NV; Sokolovskaia IV
    Ter Arkh; 1980; 52(4):55-7. PubMed ID: 7404338
    [No Abstract]   [Full Text] [Related]  

  • 8. Neurocognitive function and quality of life in relation to hematocrit levels in chronic hemodialysis patients.
    Lee SY; Lee HJ; Kim YK; Kim SH; Kim L; Lee MS; Joe SH; Jung IK; Suh KY; Kim HK
    J Psychosom Res; 2004 Jul; 57(1):5-10. PubMed ID: 15256289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of deferoxamine on erythropoiesis in patients hemodialyzed for chronic renal insufficiency treated with erythropoietin].
    Kalinowski M; Popławski A; Kaliszewski Z; Juzwiuk J
    Pol Merkur Lekarski; 1996 Oct; 1(4):232-4. PubMed ID: 9156931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Zinc in patients with chronic renal insufficiency subjected to periodic maintenance hemodialysis].
    Temes-Montes XL; Picaporte MA; Herrero E; Otero A; Sánchez-Guisande D; Sánchez-Sicilia L
    Rev Clin Esp; 1982 May; 165(3):189-91. PubMed ID: 7134531
    [No Abstract]   [Full Text] [Related]  

  • 11. [Proceedings: Determination of retention, adhesion and spreading in patients with chronic renal insufficiency, and influence of hemodialysis on platelet function parameters].
    Reuter H; Gessner K; Uibel-Nuhs H; Linker H; Sieberth G
    MMW Munch Med Wochenschr; 1974 May; 116(22):1105. PubMed ID: 4211584
    [No Abstract]   [Full Text] [Related]  

  • 12. [Low doses of recombinant erythropoietin in the treatment of renal anemia in patients on chronic hemodialysis and ambulatory peritoneal dialysis].
    Lashutin SV; Nikolaev AIu; Ermolenko VM; Shutov EV; Bezruk VG; Ivashchenko MA
    Ter Arkh; 1999; 71(6):61-3. PubMed ID: 10420460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [EEG and ENG findings in patients with chronic renal insufficiency and in hemodialysis patients].
    Sperschneider H; Stein G; Mühlau G; Both R; Fünfstück R; Wieczorek V
    Z Gesamte Inn Med; 1980 Jan; 35(1):25-8. PubMed ID: 7405295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A hematocrit greater than 36 lessens mortality and hospitalization in hemodialysis].
    Fernández-Gallego J; Gutiérrez C
    Nefrologia; 2003; 23(2):177-8. PubMed ID: 12778885
    [No Abstract]   [Full Text] [Related]  

  • 15. [Agonistic effect of calcitonin against parathormone in patients with chronic renal insufficiency on hemodialysis].
    Rico Lenza H; Huertas García-Alejo R; del Rio Vázquez A; Espinos Pérez D
    Rev Clin Esp; 1981 Sep; 162(6):271-4. PubMed ID: 7330322
    [No Abstract]   [Full Text] [Related]  

  • 16. [Physico-chemical properties of the blood of patients with chronic kidney failure].
    Gromov AE; Kulikova AI; Shostka GD; Tugusheva FA; Lukichev BG
    Vopr Med Khim; 1982; 28(6):20-4. PubMed ID: 7157718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Morphologic studies of the liver in patients in the terminal stage of chronic renal insufficiency].
    Bialik VL; Kozyr' VI; Ryb'iakova EG
    Vrach Delo; 1972 Nov; 11():82-5. PubMed ID: 4659749
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ocular hydrodynamics in chronic renal insufficiency before and after hemodialysis].
    Kolotkova AI
    Vestn Oftalmol; 1980; (3):51-2. PubMed ID: 7404943
    [No Abstract]   [Full Text] [Related]  

  • 19. Levels of serum glycosaminoglycans in renal failure.
    Mitsuhashi M; Mitsuhashi H; Yano S; Tsukada Y; Nojima Y; Naruse T
    Res Commun Mol Pathol Pharmacol; 1998 Feb; 99(2):225-32. PubMed ID: 9583096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of single-needle versus double-needle hemodialysis in chronic renal failure.
    Trakarnvanich T; Chirananthavat T; Ariyakulnimit S; Maneerat P; Chabsuwan S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S196-206. PubMed ID: 17044473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.